Get Updates
Get notified of breaking news, exclusive insights, and must-see stories!

Unichem Lab gets USFDA approval for Hydrochlorothiazide tablets

New Delhi, Aug 19 (UNI) Unichem Laboratories today said it has received the approval from US Food and Drug Administration (USFDA) for Hydrochlorothiazide tablets in the strengths of 25 mg and 50 mg.

Recently, the company had received the USFDA approval for its formulations plant situated at Ghaziabad, Uttar Pradesh.

Hydrochlorothiazide treats fluid retention (edema) in people with congestive heart failure, cirrhosis of the liver, or kidney disorders, or edema caused by taking steroids or estrogen, a company statement said.

UNI AK SR NS1807

Notifications
Settings
Clear Notifications
Notifications
Use the toggle to switch on notifications
  • Block for 8 hours
  • Block for 12 hours
  • Block for 24 hours
  • Don't block
Gender
Select your Gender
  • Male
  • Female
  • Others
Age
Select your Age Range
  • Under 18
  • 18 to 25
  • 26 to 35
  • 36 to 45
  • 45 to 55
  • 55+